Source: Bipolar disorders. Unidade: FM
Subjects: REPOSICIONAMENTO DE FÁRMACOS, ESTIMULANTES DO SISTEMA NERVOSO CENTRAL, TRANSTORNO BIPOLAR, TRANSTORNOS COGNITIVOS
ABNT
MISKOWIAK, Kamilla W et al. Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder: a systematic review by the ISBD Targeting Cognition Task Force. Bipolar disorders, v. 26, n. 3, p. 216-239, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/77039. Acesso em: 29 jun. 2025.APA
Miskowiak, K. W., Obel, Z. K., Gugliemo, R., Bonnin, C. del M., Bowie, C. R., Balanza-Martinez, V., et al. (2024). Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder: a systematic review by the ISBD Targeting Cognition Task Force. Bipolar disorders, 26( 3), 216-239. doi:10.1111/bdi.13414NLM
Miskowiak KW, Obel ZK, Gugliemo R, Bonnin C del M, Bowie CR, Balanza-Martinez V, Burdick KE, Carvalho AF, Dols A, Lafer B. Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder: a systematic review by the ISBD Targeting Cognition Task Force [Internet]. Bipolar disorders. 2024 ; 26( 3): 216-239.[citado 2025 jun. 29 ] Available from: https://observatorio.fm.usp.br/handle/OPI/77039Vancouver
Miskowiak KW, Obel ZK, Gugliemo R, Bonnin C del M, Bowie CR, Balanza-Martinez V, Burdick KE, Carvalho AF, Dols A, Lafer B. Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder: a systematic review by the ISBD Targeting Cognition Task Force [Internet]. Bipolar disorders. 2024 ; 26( 3): 216-239.[citado 2025 jun. 29 ] Available from: https://observatorio.fm.usp.br/handle/OPI/77039